To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Last viewed
- Rinne-Versuch
- Verdauungsstörung
- Sanofi-aventis: Multaq(R) Approved in the European Union for Patients With Atrial Fibrillation - First New Anti-Arrhythmic Drug to be Approved in the European Union in the Last 10 Years
- Globe Diagnostics S.r.l. - Seggiano di Pioltello (Mi), Italy
- Zealand Pharma: Additional positive results from global Phase III program with lixisenatide for Type 2 Diabetes - Results show potential for an improved blood glucose level during the day, further supporting the promising therapeutic profile of lixisenatide
